FOR IMMEDIATE RELEASE Contact: Dr. Elliot Parks, HAWAII BIOTECH INITIATES PHASE 1 CLINICAL TRIAL FOR DENGUE VACCINE (HONOLULU, August 25, Hawaii Biotech, Inc. President and CEO Elliot Parks, Ph.D.,

First Page		Document Content
Date: 2015-05-10 18:05:43 Dengue fever Microbiology Medicine Vaccines Clinical medicine Dengue vaccine Flaviviruses Virology Dengue virus Viral hemorrhagic fever Japanese encephalitis Eva Harris		FOR IMMEDIATE RELEASE Contact: Dr. Elliot Parks, HAWAII BIOTECH INITIATES PHASE 1 CLINICAL TRIAL FOR DENGUE VACCINE (HONOLULU, August 25, Hawaii Biotech, Inc. President and CEO Elliot Parks, Ph.D., Add to Reading List Source URL: www.hibiotech.com Download Document from Source Website File Size: 68,42 KB Share Document on Facebook

	Virus Reviews and Research Journal of the Brazilian Society for Virology Virus Reviews & Research Vol 20 (2), August-December 2016 Annals of the XXVII Brazilian Congress of Virology & X Mercosur Meeting of Virology Sept DocID: 1vhB7 - View Document
	Swiss Rabies Centre Institute of Virology and Immunology Länggass-StrassePO Box CH-3001 Bern S W I T Z E R L A N D DocID: 1vfbu - View Document
	Choose a stage - Choose a status Journal of General Virology: pre-submission checklist For the full pre-submission checklist required for all journals, please view our Information for Authors. Please also refer to the j DocID: 1v9EI - View Document
	Choose a stage - Choose a status Journal of General Virology: pre-submission checklist For the full pre-submission checklist required for all journals, please view our Information for Authors. Please also refer to the j DocID: 1v4y9 - View Document
	Program September 10 (Tue) 13:00 – 13:40 Training Course I: Virology Jun-ichi Sakuragi, Osaka University, Japan DocID: 1uOFr - View Document